ID   FZD4_RAT                Reviewed;         538 AA.
AC   Q9QZH0;
DT   05-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   29-MAY-2024, entry version 164.
DE   RecName: Full=Frizzled-4;
DE            Short=Fz-4;
DE            Short=rFz4;
DE   AltName: CD_antigen=CD344;
DE   Flags: Precursor;
GN   Name=Fzd4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Corpus luteum;
RA   Walther P.R., Lacher M.D., Saurer S., Friis R.R.;
RT   "Expression of a putative seven-pass transmembrane frizzled receptor in the
RT   Corpus Luteum (CL) of the rat during pregnancy and involution.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Receptor for Wnt proteins (By similarity). Most of frizzled
CC       receptors are coupled to the beta-catenin (CTNNB1) canonical signaling
CC       pathway, which leads to the activation of disheveled proteins,
CC       inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin
CC       (CTNNB1) and activation of Wnt target genes (By similarity). Plays a
CC       critical role in retinal vascularization by acting as a receptor for
CC       Wnt proteins and norrin (NDP) (By similarity). In retina, it can be
CC       both activated by Wnt protein-binding, but also by a Wnt-independent
CC       signaling via binding of norrin (NDP), promoting in both cases beta-
CC       catenin (CTNNB1) accumulation and stimulation of LEF/TCF-mediated
CC       transcriptional programs (By similarity). A second signaling pathway
CC       involving PKC and calcium fluxes has been seen for some family members,
CC       but it is not yet clear if it represents a distinct pathway or if it
CC       can be integrated in the canonical pathway, as PKC seems to be required
CC       for Wnt-mediated inactivation of GSK-3 kinase (By similarity). Both
CC       pathways seem to involve interactions with G-proteins (By similarity).
CC       May be involved in transduction and intercellular transmission of
CC       polarity information during tissue morphogenesis and/or in
CC       differentiated tissues (By similarity). {ECO:0000250|UniProtKB:Q61088,
CC       ECO:0000250|UniProtKB:Q9ULV1}.
CC   -!- SUBUNIT: Interacts with MAGI3 and NDP. Component of a complex, at least
CC       composed of TSPAN12, FZD4 and norrin (NDP). Interacts (via FZ domain)
CC       with TSKU; TSKU competes with WNT2B for binding to FZD4, inhibiting Wnt
CC       signaling and repressing peripheral eye development. Interacts with
CC       glypican GPC3. {ECO:0000250|UniProtKB:Q61088,
CC       ECO:0000250|UniProtKB:Q9ULV1}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q9ULV1};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- DOMAIN: Lys-Thr-X-X-X-Trp motif interacts with the PDZ domain of Dvl
CC       (Disheveled) family members and is involved in the activation of the
CC       Wnt/beta-catenin signaling pathway. {ECO:0000250}.
CC   -!- DOMAIN: The FZ domain is involved in binding with Wnt ligands.
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitinated by ZNRF3, leading to its degradation by the
CC       proteasome. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor Fz/Smo family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF183910; AAF01036.1; -; mRNA.
DR   RefSeq; NP_072145.1; NM_022623.2.
DR   AlphaFoldDB; Q9QZH0; -.
DR   SMR; Q9QZH0; -.
DR   STRING; 10116.ENSRNOP00000023205; -.
DR   GlyCosmos; Q9QZH0; 3 sites, No reported glycans.
DR   GlyGen; Q9QZH0; 3 sites.
DR   PhosphoSitePlus; Q9QZH0; -.
DR   PaxDb; 10116-ENSRNOP00000023205; -.
DR   Ensembl; ENSRNOT00000106139.1; ENSRNOP00000088712.1; ENSRNOG00000063590.1.
DR   Ensembl; ENSRNOT00055033049; ENSRNOP00055026776; ENSRNOG00055019371.
DR   Ensembl; ENSRNOT00060036795; ENSRNOP00060030306; ENSRNOG00060021248.
DR   Ensembl; ENSRNOT00065049779; ENSRNOP00065040867; ENSRNOG00065028846.
DR   GeneID; 64558; -.
DR   KEGG; rno:64558; -.
DR   UCSC; RGD:71017; rat.
DR   AGR; RGD:71017; -.
DR   CTD; 8322; -.
DR   RGD; 71017; Fzd4.
DR   eggNOG; KOG3577; Eukaryota.
DR   GeneTree; ENSGT00940000157141; -.
DR   HOGENOM; CLU_007873_2_1_1; -.
DR   InParanoid; Q9QZH0; -.
DR   OMA; HWGEFRA; -.
DR   OrthoDB; 5483535at2759; -.
DR   PhylomeDB; Q9QZH0; -.
DR   TreeFam; TF317907; -.
DR   Reactome; R-RNO-4086398; Ca2+ pathway.
DR   Reactome; R-RNO-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-RNO-4641263; Regulation of FZD by ubiquitination.
DR   Reactome; R-RNO-5099900; WNT5A-dependent internalization of FZD4.
DR   Reactome; R-RNO-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   PRO; PR:Q9QZH0; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000016848; Expressed in skeletal muscle tissue and 18 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0001540; F:amyloid-beta binding; ISO:RGD.
DR   GO; GO:0019955; F:cytokine binding; ISO:RGD.
DR   GO; GO:0004896; F:cytokine receptor activity; ISO:RGD.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0030165; F:PDZ domain binding; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:RGD.
DR   GO; GO:0038023; F:signaling receptor activity; IGI:ARUK-UCL.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0042813; F:Wnt receptor activity; ISO:RGD.
DR   GO; GO:0017147; F:Wnt-protein binding; IPI:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISO:RGD.
DR   GO; GO:0001568; P:blood vessel development; ISO:RGD.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; ISO:RGD.
DR   GO; GO:0061301; P:cerebellum vasculature morphogenesis; ISO:RGD.
DR   GO; GO:0045446; P:endothelial cell differentiation; ISO:RGD.
DR   GO; GO:0060856; P:establishment of blood-brain barrier; ISO:RGD.
DR   GO; GO:0035426; P:extracellular matrix-cell signaling; ISO:RGD.
DR   GO; GO:0031987; P:locomotion involved in locomotory behavior; ISO:RGD.
DR   GO; GO:0001553; P:luteinization; ISO:RGD.
DR   GO; GO:0010812; P:negative regulation of cell-substrate adhesion; ISO:RGD.
DR   GO; GO:0035567; P:non-canonical Wnt signaling pathway; IBA:GO_Central.
DR   GO; GO:0110135; P:Norrin signaling pathway; ISO:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; IMP:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0150012; P:positive regulation of neuron projection arborization; IGI:ARUK-UCL.
DR   GO; GO:0030177; P:positive regulation of Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0042701; P:progesterone secretion; ISO:RGD.
DR   GO; GO:0030947; P:regulation of vascular endothelial growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   GO; GO:0061298; P:retina vasculature development in camera-type eye; ISO:RGD.
DR   GO; GO:0061299; P:retina vasculature morphogenesis in camera-type eye; ISO:RGD.
DR   GO; GO:0061304; P:retinal blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; ISO:RGD.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; ISO:RGD.
DR   GO; GO:0001570; P:vasculogenesis; ISO:RGD.
DR   GO; GO:0016055; P:Wnt signaling pathway; IGI:ARUK-UCL.
DR   GO; GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; ISO:RGD.
DR   CDD; cd15038; 7tmF_FZD4; 1.
DR   CDD; cd07448; CRD_FZ4; 1.
DR   Gene3D; 1.10.2000.10; Frizzled cysteine-rich domain; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR015526; Frizzled/SFRP.
DR   InterPro; IPR000539; Frizzled/Smoothened_7TM.
DR   InterPro; IPR020067; Frizzled_dom.
DR   InterPro; IPR036790; Frizzled_dom_sf.
DR   InterPro; IPR041765; FZ4_CRD.
DR   InterPro; IPR026551; FZD4_7TM.
DR   InterPro; IPR017981; GPCR_2-like_7TM.
DR   PANTHER; PTHR11309; FRIZZLED; 1.
DR   PANTHER; PTHR11309:SF23; FRIZZLED-4; 1.
DR   Pfam; PF01534; Frizzled; 1.
DR   Pfam; PF01392; Fz; 1.
DR   PRINTS; PR00489; FRIZZLED.
DR   SMART; SM00063; FRI; 1.
DR   SMART; SM01330; Frizzled; 1.
DR   SUPFAM; SSF63501; Frizzled cysteine-rich domain; 1.
DR   PROSITE; PS50038; FZ; 1.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Developmental protein; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Receptor;
KW   Reference proteome; Signal; Transducer; Transmembrane; Transmembrane helix;
KW   Ubl conjugation; Wnt signaling pathway.
FT   SIGNAL          1..37
FT                   /evidence="ECO:0000255"
FT   CHAIN           38..538
FT                   /note="Frizzled-4"
FT                   /id="PRO_0000012987"
FT   TOPO_DOM        38..213
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   TRANSMEM        214..244
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   TOPO_DOM        245..250
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   TRANSMEM        251..276
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   TOPO_DOM        277..300
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   TRANSMEM        301..334
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   TOPO_DOM        335..337
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   TRANSMEM        338..366
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   TOPO_DOM        367..384
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   TRANSMEM        385..419
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   TOPO_DOM        420..432
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   TRANSMEM        433..461
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   TOPO_DOM        462..474
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   TRANSMEM        475..496
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   TOPO_DOM        497..538
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   DOMAIN          41..162
FT                   /note="FZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   MOTIF           500..505
FT                   /note="Lys-Thr-X-X-X-Trp motif, mediates interaction with
FT                   the PDZ domain of Dvl family members"
FT                   /evidence="ECO:0000250"
FT   MOTIF           536..538
FT                   /note="PDZ-binding"
FT   CARBOHYD        60
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        145
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        382
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        46..107
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   DISULFID        54..100
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   DISULFID        91..129
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   DISULFID        118..159
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   DISULFID        122..146
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   DISULFID        182..201
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   DISULFID        205..283
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
FT   DISULFID        303..378
FT                   /evidence="ECO:0000250|UniProtKB:Q9ULV1"
SQ   SEQUENCE   538 AA;  60355 MW;  07DAAE606B46E005 CRC64;
     MAWQGTGPSV RGMPGGVRLR LGLLLLQLLL LQRPALGFGD EEERRCDPIR IAMCQNLGYN
     VTKMPNLVGH ELQTDAELQL TTFTPLIQYG CSSQLQFFLC SVYVPMCTEK INIPIGPCGG
     MCLSVKRRCE PVLKEFGFAW PDSLNCSKFP PQNDHNHMCM EGPGDEEVPL PHKTPIQPGE
     ECHSVGTNSD QYIWVKRSLN CVLKCGYDAG LYSRSAKEFT DIWMAVWASL CFISTTFTVL
     TFLIDSSRFS YPERPIIFLS MCYNIYSIAY IVRLTVGRER ISCDFEEAAE PVLIQEGLKN
     TGCAIIFLLM YFFGMASSIW WVILTLTWFL AAGLKWGHEA IEMHSSYFHI AAWAIPAVKT
     IVILIMRLVD ADELTGLCYV GNQSLDALTG FVVAPLFTYL VIGTLFIAAG LVALFKIRSN
     LQKDGTKTDK LERLMVKIGV FSVLYTVPAT CVIACYFYEI SNWALFRYSA DDSNMAVEML
     KIFMSLLVGI TSGMWIWSAK TLHTWQKCSN RLVNSGKVKR EKRGNGWVKP GKGNETVV
//
